CellabMED
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Clinical Study of IL13Rα2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I) Recurrent Malignant Glioma | Phase 1 | 2022-07-18 |
| Completed | To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patie Colorectal Cancer Metastatic, Colorectal Cancer Recurrent | Phase 1 / Phase 2 | 2019-08-09 |
| Completed | Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard T Solid Tumors | Phase 1 | 2015-07-13 |